|
MTMR12 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.34270389146241E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.79000045289024E-10 |
| Normal-vs-Stage2 |
1.568150E-04 |
| Normal-vs-Stage3 |
2.608600E-04 |
| Normal-vs-Stage4 |
9.191500E-04 |
| Stage1-vs-Stage2 |
9.318400E-01 |
| Stage1-vs-Stage3 |
8.352000E-01 |
| Stage1-vs-Stage4 |
4.086400E-01 |
| Stage2-vs-Stage3 |
9.249800E-01 |
| Stage2-vs-Stage4 |
3.161000E-01 |
| Stage3-vs-Stage4 |
3.334400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07379993785628E-10 |
| Normal-vs-AfricanAmerican |
6.38819996900963E-09 |
| Normal-vs-Asian |
1.85590000034708E-08 |
| Caucasian-vs-AfricanAmerican |
7.115400E-01 |
| Caucasian-vs-Asian |
1.217430E-01 |
| AfricanAmerican-vs-Asian |
7.815900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.25450777438618E-12 |
| Normal-vs-Female |
2.231600E-04 |
| Male-vs-Female |
1.148380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.5849000001289E-07 |
| Normal-vs-Extreme_Weight |
2.54679999311946E-09 |
| Normal-vs-Obese |
2.36540000031482E-07 |
| Normal-vs-Extreme_Obese |
2.281600E-03 |
| Normal_Weight-vs-Extreme_Weight |
9.441000E-01 |
| Normal_Weight-vs-Obese |
2.756800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.388200E-01 |
| Extreme_Weight-vs-Obese |
2.115000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.975200E-01 |
| Obese-vs-Extreme_Obese |
2.953000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.996400E-04 |
| Normal-vs-Age(41-60Yrs) |
1.62999999997471E-06 |
| Normal-vs-Age(61-80Yrs) |
2.8377300509419E-13 |
| Normal-vs-Age(81-100Yrs) |
1.071620E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.308400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.153200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.080200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.501720E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.384600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.374000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.45959919098482E-11 |
| Normal-VS-Type2 PRCC |
1.84559999505396E-08 |
| Normal-VS-KIRP CIMP |
4.70060002033534E-09 |
| Normal-VS-Unclassified PRCC |
2.188000E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.408800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.499010E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.802200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.940100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.173700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.360500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.01447755646223E-12 |
| Normal-vs-N1 |
2.771900E-04 |
| Normal-vs-N2 |
2.01490000018012E-07 |
| N0-vs-N1 |
2.156200E-01 |
| N0-vs-N2 |
2.244000E-01 |
| N1-vs-N2 |
1.546170E-01 |
|
|
